DUBLIN--(BUSINESS WIRE)--The "Global Metabolomics Market 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The metabolomics market will register a CAGR of nearly 12% by 2023.
High potential for new techniques in metabolomics to emerge as a major trend
New techniques in metabolomics are gaining widespread popularity among scientists and researchers due to their increased potential for fast and simultaneous fingerprinting of a vast number of metabolites.
Many of the above professionals use multiple separation techniques such as high-performance liquid chromatography (HPLC), UPLC, ion chromatography-mass spectrometry (IC-MS), GC, and LC, and other detection techniques such as MS-NMR, surface-based mass analysis, and metabolite profiling for successful and comprehensive metabolite coverage.
Rising demand for early and accurate diagnosis
In recent years, the field of metabolomics has shown significant potential in early disease diagnosis, therapy monitoring, and understanding the pathogenesis of different diseases. Since metabolomics methods focus on analytical techniques such as N MR spectroscopy and MS, the analyses from these high-resolution methods using advanced chemometric approaches can provide a powerful platform for translational/clinical research and diagnostic applications.
Lack of skilled professionals
Research analysis of samples using metabolomics tools requires the assistance of skilled professionals to design experiments, collect the samples, extract the samples, and generate metabolomic data. These professionals must have in-depth knowledge of analytical methods such as mass spectrometry and nuclear magnetic resonance, which are used in performing experiments.
Competitive Landscape
The market appears to be fragmented, and with the presence of several companies including Bruker and Human Metabolome Technologies, the competitive environment is quite intense.
Key Players
- Agilent Technologies
- Bio-Rad Laboratories
- Bruker
- Human Metabolome Technologies
- Metabolon
Topics Covered
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
- Comparison by application
- Biomarker and drug discovery - Market size and forecast 2018-2023
- Nutrigenomics - Market size and forecast 2018-2023
- Toxicology testing - Market size and forecast 2018-2023
- Market opportunity by application
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic comparison
- North America - Market size and forecast 2018-2023
- Europe - Market size and forecast 2018-2023
- Asia - Market size and forecast 2018-2023
- ROW - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DRIVERS AND CHALLENGES
PART 10: MARKET TRENDS
- Increasing applications of metabolomics
- High potential for new techniques in metabolomics
- New developments in the field of metabolomics
PART 11: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 12: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Agilent Technologies
- Bio-Rad Laboratories
- Bruker
- Human Metabolome Technologies
- Metabolon
For more information about this report visit https://www.researchandmarkets.com/research/ttn9wt/global?w=4
